Alert button
Picture for Paul Bilokon

Paul Bilokon

Alert button

Applying Deep Learning to Calibrate Stochastic Volatility Models

Add code
Bookmark button
Alert button
Sep 25, 2023
Abir Sridi, Paul Bilokon

Figure 1 for Applying Deep Learning to Calibrate Stochastic Volatility Models
Figure 2 for Applying Deep Learning to Calibrate Stochastic Volatility Models
Figure 3 for Applying Deep Learning to Calibrate Stochastic Volatility Models
Figure 4 for Applying Deep Learning to Calibrate Stochastic Volatility Models
Viaarxiv icon

Transformers versus LSTMs for electronic trading

Add code
Bookmark button
Alert button
Sep 20, 2023
Paul Bilokon, Yitao Qiu

Figure 1 for Transformers versus LSTMs for electronic trading
Figure 2 for Transformers versus LSTMs for electronic trading
Figure 3 for Transformers versus LSTMs for electronic trading
Figure 4 for Transformers versus LSTMs for electronic trading
Viaarxiv icon

A compendium of data sources for data science, machine learning, and artificial intelligence

Add code
Bookmark button
Alert button
Sep 10, 2023
Paul Bilokon, Oleksandr Bilokon, Saeed Amen

Viaarxiv icon

Exploring the Advantages of Transformers for High-Frequency Trading

Add code
Bookmark button
Alert button
Feb 20, 2023
Fazl Barez, Paul Bilokon, Arthur Gervais, Nikita Lisitsyn

Figure 1 for Exploring the Advantages of Transformers for High-Frequency Trading
Figure 2 for Exploring the Advantages of Transformers for High-Frequency Trading
Figure 3 for Exploring the Advantages of Transformers for High-Frequency Trading
Figure 4 for Exploring the Advantages of Transformers for High-Frequency Trading
Viaarxiv icon

Identification and validation of Triamcinolone and Gallopamil as treatments for early COVID-19 via an in silico repurposing pipeline

Add code
Bookmark button
Alert button
Jul 05, 2021
Méabh MacMahon, Woochang Hwang, Soorin Yim, Eoghan MacMahon, Alexandre Abraham, Justin Barton, Mukunthan Tharmakulasingam, Paul Bilokon, Vasanthi Priyadarshini Gaddi, Namshik Han

Figure 1 for Identification and validation of Triamcinolone and Gallopamil as treatments for early COVID-19 via an in silico repurposing pipeline
Figure 2 for Identification and validation of Triamcinolone and Gallopamil as treatments for early COVID-19 via an in silico repurposing pipeline
Viaarxiv icon